Cargando…
Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies
It has been well established that the etiopathogenesis of diverse autoimmune diseases is rooted in the autoreactive immune cells’ excessively proliferative state and impaired apoptotic machinery. Survivin is an anti-apoptotic and mitotic factor that has sparked a considerable research interest in th...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927965/ https://www.ncbi.nlm.nih.gov/pubmed/35309327 http://dx.doi.org/10.3389/fimmu.2022.839945 |
_version_ | 1784670557964337152 |
---|---|
author | Shomali, Navid Suliman Maashi, Marwah Baradaran, Behzad Daei Sorkhabi, Amin Sarkesh, Aila Mohammadi, Hamed Hemmatzadeh, Maryam Marofi, Faroogh Sandoghchian Shotorbani, Siamak Jarahian, Mostafa |
author_facet | Shomali, Navid Suliman Maashi, Marwah Baradaran, Behzad Daei Sorkhabi, Amin Sarkesh, Aila Mohammadi, Hamed Hemmatzadeh, Maryam Marofi, Faroogh Sandoghchian Shotorbani, Siamak Jarahian, Mostafa |
author_sort | Shomali, Navid |
collection | PubMed |
description | It has been well established that the etiopathogenesis of diverse autoimmune diseases is rooted in the autoreactive immune cells’ excessively proliferative state and impaired apoptotic machinery. Survivin is an anti-apoptotic and mitotic factor that has sparked a considerable research interest in this field. Survivin overexpression has been shown to contribute significantly to the development of autoimmune diseases via autoreactive immune cell overproliferation and apoptotic dysregulation. Several microRNAs (miRNAs/miRs) have been discovered to be involved in survivin regulation, rendering the survivin-miRNA axis a perspective target for autoimmune disease therapy. In this review, we discuss the role of survivin as an immune regulator and a highly implicated protein in the pathogenesis of autoimmune diseases, the significance of survivin-targeting miRNAs in autoimmunity, and the feasibility of targeting the survivin-miRNA axis as a promising therapeutic option for autoimmune diseases. |
format | Online Article Text |
id | pubmed-8927965 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89279652022-03-18 Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies Shomali, Navid Suliman Maashi, Marwah Baradaran, Behzad Daei Sorkhabi, Amin Sarkesh, Aila Mohammadi, Hamed Hemmatzadeh, Maryam Marofi, Faroogh Sandoghchian Shotorbani, Siamak Jarahian, Mostafa Front Immunol Immunology It has been well established that the etiopathogenesis of diverse autoimmune diseases is rooted in the autoreactive immune cells’ excessively proliferative state and impaired apoptotic machinery. Survivin is an anti-apoptotic and mitotic factor that has sparked a considerable research interest in this field. Survivin overexpression has been shown to contribute significantly to the development of autoimmune diseases via autoreactive immune cell overproliferation and apoptotic dysregulation. Several microRNAs (miRNAs/miRs) have been discovered to be involved in survivin regulation, rendering the survivin-miRNA axis a perspective target for autoimmune disease therapy. In this review, we discuss the role of survivin as an immune regulator and a highly implicated protein in the pathogenesis of autoimmune diseases, the significance of survivin-targeting miRNAs in autoimmunity, and the feasibility of targeting the survivin-miRNA axis as a promising therapeutic option for autoimmune diseases. Frontiers Media S.A. 2022-03-03 /pmc/articles/PMC8927965/ /pubmed/35309327 http://dx.doi.org/10.3389/fimmu.2022.839945 Text en Copyright © 2022 Shomali, Suliman Maashi, Baradaran, Daei Sorkhabi, Sarkesh, Mohammadi, Hemmatzadeh, Marofi, Sandoghchian Shotorbani and Jarahian https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Shomali, Navid Suliman Maashi, Marwah Baradaran, Behzad Daei Sorkhabi, Amin Sarkesh, Aila Mohammadi, Hamed Hemmatzadeh, Maryam Marofi, Faroogh Sandoghchian Shotorbani, Siamak Jarahian, Mostafa Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies |
title | Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies |
title_full | Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies |
title_fullStr | Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies |
title_full_unstemmed | Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies |
title_short | Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies |
title_sort | dysregulation of survivin-targeting micrornas in autoimmune diseases: new perspectives for novel therapies |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927965/ https://www.ncbi.nlm.nih.gov/pubmed/35309327 http://dx.doi.org/10.3389/fimmu.2022.839945 |
work_keys_str_mv | AT shomalinavid dysregulationofsurvivintargetingmicrornasinautoimmunediseasesnewperspectivesfornoveltherapies AT sulimanmaashimarwah dysregulationofsurvivintargetingmicrornasinautoimmunediseasesnewperspectivesfornoveltherapies AT baradaranbehzad dysregulationofsurvivintargetingmicrornasinautoimmunediseasesnewperspectivesfornoveltherapies AT daeisorkhabiamin dysregulationofsurvivintargetingmicrornasinautoimmunediseasesnewperspectivesfornoveltherapies AT sarkeshaila dysregulationofsurvivintargetingmicrornasinautoimmunediseasesnewperspectivesfornoveltherapies AT mohammadihamed dysregulationofsurvivintargetingmicrornasinautoimmunediseasesnewperspectivesfornoveltherapies AT hemmatzadehmaryam dysregulationofsurvivintargetingmicrornasinautoimmunediseasesnewperspectivesfornoveltherapies AT marofifaroogh dysregulationofsurvivintargetingmicrornasinautoimmunediseasesnewperspectivesfornoveltherapies AT sandoghchianshotorbanisiamak dysregulationofsurvivintargetingmicrornasinautoimmunediseasesnewperspectivesfornoveltherapies AT jarahianmostafa dysregulationofsurvivintargetingmicrornasinautoimmunediseasesnewperspectivesfornoveltherapies |